All-cause mortality among patients treated with repurposed antivirals and antibiotics for COVID-19 in Mexico City: A real-world observational study

The aim of our study was to evaluate all-cause mortality risk in patients with laboratory-confirmed COVID-19 in Mexico City treated with repurposed antivirals and antibiotics. This real-world retrospective cohort study contemplated 395,343 patients evaluated for suspected COVID-19 between February 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Mancilla-Galindo, Javier, García-Méndez, Jorge Óscar, Márquez-Sánchez, Jessica, Reyes-Casarrubias, Rodrigo Estefano, Aguirre-Aguilar, Eduardo, Rocha-González, Héctor Isaac, Kammar-García, Ashuin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Leibniz Research Centre for Working Environment and Human Factors 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898041/
https://www.ncbi.nlm.nih.gov/pubmed/33628159
http://dx.doi.org/10.17179/excli2021-3413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898041/
https://www.ncbi.nlm.nih.gov/pubmed/33628159
http://dx.doi.org/10.17179/excli2021-3413

Ejemplares similares